Provided by Tiger Trade Technology Pte. Ltd.

Core & Main, Inc.

41.14
-0.4600-1.11%
Volume:1.96M
Turnover:81.39M
Market Cap:7.85B
PE:17.44
High:41.90
Open:40.85
Low:40.76
Close:41.60
52wk High:59.66
52wk Low:40.76
Shares:190.80M
Float Shares:190.40M
Volume Ratio:1.27
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.36
EPS(LYR):2.31
ROE:23.56%
ROA:7.13%
PB:3.86
PE(LYR):17.81

Loading ...

Core & Main - Reaffirms Full-Year Fiscal 2026 Outlook Issued in March 2026

THOMSON REUTERS
·
Sep 09

Core & Main FY26 Q2 Net Income Climbs 6.4% to $150 Million; Net Sales Rise 2.5% to $2.15 Billion

Reuters
·
Sep 09

U.S. Earnings Preview: Before Market Open Sept. 9

Dow Jones
·
Sep 09

Top Wall Street Forecasters Revamp Core & Main Expectations Ahead Of Q2 Earnings

Benzinga Earnings
·
Sep 09

Signet Jewelers, Casey's General Stores and 3 Stocks to Watch Heading Into Wednesday

Benzinga Earnings
·
Sep 09

Top News Today/Canada: Carney Vows to Backstop Economy Amid U.S. Trade Row

Dow Jones
·
Sep 09

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 04

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 02

Earning Preview: Core & Main, Inc. This quarter’s revenue is expected to increase by 0.71%, and institutional views are predominantly bullish

Earnings Agent
·
Sep 02

Press Release: Core & Main to Announce Fiscal 2026 Second Quarter Results

Dow Jones
·
Aug 27

Core & Main Shares Fall After Northcoast Downgrade

MT Newswires Live
·
Aug 27

Northcoast Downgrades Core & Main to Neutral From Buy

MT Newswires Live
·
Aug 26

Core & Main downgraded to Neutral from Buy at Northcoast

TIPRANKS
·
Aug 26

Wall Street Analysts Are Bullish on Top Industrial Goods Picks

TIPRANKS
·
Aug 25

Clene reports Q2 EPS ($1.08), consensus (26c)

TIPRANKS
·
Aug 16

Press Release: Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights

Dow Jones
·
Aug 14

Buy Rating Reaffirmed on CNM-Au8 ALS Progress, Regulatory Momentum; $31 Price Target Maintained

TIPRANKS
·
Aug 11

Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval

GlobeNewswire
·
Aug 10

Core & Main Initiated at Market Perform by William Blair

Dow Jones
·
Jul 23